PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Medifast, Inc. (MED)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US58470H1014

CUSIP

58470H101

Sector

Consumer Cyclical

IPO Date

Dec 31, 1993

Highlights

Market Cap

$203.33M

EPS (TTM)

$0.67

PE Ratio

27.75

PEG Ratio

1.95

Total Revenue (TTM)

$674.48M

Gross Profit (TTM)

$497.77M

EBITDA (TTM)

$20.46M

Year Range

$17.07 - $70.58

Target Price

$16.50

Short %

22.52%

Short Ratio

7.68

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
MED vs. CBRL MED vs. JWN MED vs. SCHD MED vs. NEE MED vs. HD MED vs. IVV MED vs. VFC MED vs. VOO MED vs. GPC MED vs. LOW
Popular comparisons:
MED vs. CBRL MED vs. JWN MED vs. SCHD MED vs. NEE MED vs. HD MED vs. IVV MED vs. VFC MED vs. VOO MED vs. GPC MED vs. LOW

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Medifast, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-15.00%-10.00%-5.00%0.00%5.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-16.63%
7.20%
MED (Medifast, Inc.)
Benchmark (^GSPC)

Returns By Period

Medifast, Inc. had a return of -74.50% year-to-date (YTD) and -74.42% in the last 12 months. Over the past 10 years, Medifast, Inc. had an annualized return of -3.78%, while the S&P 500 had an annualized return of 10.96%, indicating that Medifast, Inc. did not perform as well as the benchmark.


MED

YTD

-74.50%

1M

-1.04%

6M

-16.63%

1Y

-74.42%

5Y*

-27.96%

10Y*

-3.78%

^GSPC (Benchmark)

YTD

23.00%

1M

-0.84%

6M

7.20%

1Y

24.88%

5Y*

12.77%

10Y*

10.96%

Monthly Returns

The table below presents the monthly returns of MED, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-18.70%-26.64%-4.42%-28.16%-6.50%-15.23%0.50%-16.55%4.59%-3.97%7.02%-74.50%
2023-3.38%0.61%-5.95%-11.59%-14.13%19.33%10.56%-17.22%-9.41%-7.60%-4.02%1.27%-38.34%
2022-5.12%-6.40%-7.29%4.44%-6.51%9.20%-6.83%-25.39%-12.44%7.96%7.74%-7.19%-42.31%
202119.52%7.81%-15.74%7.21%46.31%-14.37%0.89%-20.18%-14.92%1.88%4.83%2.48%9.36%
2020-11.82%-13.99%-23.47%21.41%34.87%36.77%20.44%-2.64%1.73%-14.57%45.31%-3.28%86.18%
20191.78%0.15%0.68%15.01%-12.09%0.09%-12.98%-10.47%4.41%7.05%-20.76%25.97%-9.73%
2018-1.58%-7.16%47.29%7.42%45.94%9.67%7.19%33.24%-2.92%-4.45%-29.85%-15.31%82.11%
20171.30%6.33%-0.32%4.39%-10.17%0.43%2.94%32.63%5.44%5.10%9.82%2.55%72.33%
2016-4.44%4.55%0.36%4.44%1.21%5.07%5.86%4.40%3.46%8.65%-4.82%7.33%41.31%
2015-5.54%-0.16%-5.28%0.10%7.30%0.40%-4.49%-10.04%-3.28%4.13%8.40%1.02%-8.71%
20141.53%-0.72%10.44%8.80%-0.69%-3.25%-5.59%17.03%-2.29%-3.32%-7.06%13.73%28.40%
2013-7.05%-5.50%-1.12%14.31%9.96%-10.59%6.13%-9.07%8.17%-13.31%16.22%-3.54%-0.99%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MED is 5, meaning it’s performing worse than 95% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of MED is 55
Overall Rank
The Sharpe Ratio Rank of MED is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of MED is 11
Sortino Ratio Rank
The Omega Ratio Rank of MED is 11
Omega Ratio Rank
The Calmar Ratio Rank of MED is 66
Calmar Ratio Rank
The Martin Ratio Rank of MED is 1919
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Medifast, Inc. (MED) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for MED, currently valued at -1.37, compared to the broader market-4.00-2.000.002.00-1.371.83
The chart of Sortino ratio for MED, currently valued at -2.66, compared to the broader market-4.00-2.000.002.004.00-2.662.46
The chart of Omega ratio for MED, currently valued at 0.68, compared to the broader market0.501.001.502.000.681.34
The chart of Calmar ratio for MED, currently valued at -0.79, compared to the broader market0.002.004.006.00-0.792.72
The chart of Martin ratio for MED, currently valued at -1.20, compared to the broader market0.0010.0020.00-1.2011.89
MED
^GSPC

The current Medifast, Inc. Sharpe ratio is -1.37. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Medifast, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-1.37
1.83
MED (Medifast, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

Medifast, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


1.00%2.00%3.00%4.00%5.00%6.00%7.00%$0.00$1.00$2.00$3.00$4.00$5.00$6.00$7.00201520162017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM202320222021202020192018201720162015
Dividend$0.00$4.95$6.56$5.68$4.52$3.38$2.19$1.44$1.07$0.25

Dividend yield

0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%

Monthly Dividends

The table displays the monthly dividend distributions for Medifast, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$1.65$0.00$0.00$1.65$0.00$0.00$1.65$0.00$0.00$0.00$4.95
2022$0.00$0.00$1.64$0.00$0.00$1.64$0.00$0.00$1.64$0.00$0.00$1.64$6.56
2021$0.00$0.00$1.42$0.00$0.00$1.42$0.00$0.00$1.42$0.00$0.00$1.42$5.68
2020$0.00$0.00$1.13$0.00$0.00$1.13$0.00$0.00$1.13$0.00$0.00$1.13$4.52
2019$0.00$0.00$0.75$0.00$0.00$0.75$0.00$0.00$0.75$0.00$0.00$1.13$3.38
2018$0.00$0.00$0.48$0.00$0.00$0.48$0.00$0.00$0.48$0.00$0.00$0.75$2.19
2017$0.00$0.00$0.32$0.00$0.00$0.32$0.00$0.00$0.32$0.00$0.00$0.48$1.44
2016$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.32$1.07
2015$0.25$0.25

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-94.18%
-3.66%
MED (Medifast, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Medifast, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Medifast, Inc. was 98.33%, occurring on Dec 23, 1999. Recovery took 534 trading sessions.

The current Medifast, Inc. drawdown is 94.18%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.33%Feb 9, 19941254Dec 23, 1999534Dec 27, 20021788
-94.18%Jun 1, 2021896Dec 19, 2024
-85.56%Nov 7, 2003330Mar 2, 2005316Jun 2, 2006646
-83.16%Jun 22, 2006611Nov 21, 2008204Sep 16, 2009815
-78.91%Sep 13, 2018380Mar 18, 2020215Jan 25, 2021595

Volatility

Volatility Chart

The current Medifast, Inc. volatility is 15.67%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember
15.67%
3.62%
MED (Medifast, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Medifast, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Medifast, Inc. compared to its peers in the Personal Services industry.


PE Ratio
50.0100.0150.027.7
The chart displays the price to earnings (P/E) ratio for MED in comparison to other companies of the Personal Services industry. Currently, MED has a PE value of 27.7. This PE ratio falls in the average range for the industry.
PEG Ratio
1.02.03.04.02.0
The chart displays the price to earnings to growth (PEG) ratio for MED in comparison to other companies of the Personal Services industry. Currently, MED has a PEG value of 2.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Medifast, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab